A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors | MicrobiomeTrials← Back to trialsNCT07287995
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-02-05Est. Completion: 2029-06-30
Enrollment target: 428 participants Locations- AdventHealth Medical Group Oncology Research Celebration, Celebration, Florida, United States
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
- START New York Long Island, New Hyde Park, New York, United States
- Tennessee Oncology, Nashville, Tennessee, United States
- NEXT Virginia, Fairfax, Virginia, United States
- National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
- Kansai Medical University Hospital, Hirakata-shi, Osaka, Japan
- National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
- The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan
Other microbiome trials you might be interested in
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Locally Advanced Malignant Solid NeoplasmMalignant Female Reproductive System NeoplasmMetastatic HER2-Negative Breast CarcinomaMetastatic Malignant Solid NeoplasmRecurrent Endometrial CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Malignant Female Reproductive System NeoplasmRecurrent Malignant Solid NeoplasmRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaUnresectable HER2-Negative Breast CarcinomaUnresectable Malignant Solid Neoplasm
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment…
Birmingham, United StatesEst. completion Jul 1, 2030
Malignant Neoplasm
Researchers are looking for new ways to treat adolescents with locally advanced, unresectable, or metastatic solid tumor…
Iowa City, United StatesEst. completion Jan 2, 2034
Clear Cell Renal Cell CarcinomaLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmMetastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8
This phase II trial studies how well adavosertib works in treating patients with SETD2-deficient solid tumors that have …
Orange, United StatesEst. completion Mar 1, 2026